Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3/5
Grifols SA

Grifols SA (GRF SM)

77
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols SA
27 Nov 2024 22:52

Brookfield's Bid for Grifols Collapses

​Brookfield withdraws €6.45 billion takeover bid for Grifols due to valuation disagreements, shareholder resistance, and financing challenges.

Share
bullishGrifols SA
20 Nov 2024 08:18

Lowball Non-Binding Indication from Brookfield

Rejected Offer: Grifols' independent committee rejected Brookfield's proposed valuation of €10.50 per Class A share, citing significant...

Share
bullishGrifols SA
18 Nov 2024 14:21

Liquid Universe of European Ordinary and Preferred Shares: November‘24 Report

Since mid-October, share-price spreads have generally tightened across European liquid universe of ordinary and preferred shares (10 have...

Share
bullishGrifols SA
14 Nov 2024 17:28

Brookfield Refinances Grifols' Debt

Brookfield has secured an €11 billion loan to refinance Grifols’ debt, paving the way for a potential takeover and significant control over...

Share
bearishGrifols SA
28 Oct 2024 22:45

Brookfield Delays Its Takeover Bid for Grifols for a Second Time

Brookfield’s acquisition bid for Grifols has been delayed for a second time due to funding issues, raising investor concerns.

Share
x